Transformative Trends Impacting the Chronic Kidney Disease Market Landscape: Innovative Products Drive Growth In The Chronic Kidney Disease Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Chronic Kidney Disease Market Size By 2025?
In recent times, there has been a noticeable expansion in the chronic kidney disease market, with its size expected to escalate from $70.65 billion in 2024 to $75.09 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.3%. The substantial growth witnessed during the historic period can be attributed to several factors such as the prevalence of hypertension and diabetes, an increase in the aging population, unhealthy lifestyle choices, uneven access to healthcare facilities, and significant advancements in the medical field.

How Big Is the Chronic Kidney Disease Market Size Expected to Grow by 2029?
The market size for chronic kidney disease is anticipated to witness robust expansion in the coming years, potentially reaching $95.85 billion by 2029 with a CAGR of 6.3%. Factors contributing to this projected growth during the forecast period include a focus on healthcare policies, progression in precision medicine, increasing obesity rates, the prevalence of chronic diseases, and enhanced access to healthcare. Prevailing trends in the forecast period encompass early detection drives, telemedicine and distant surveillance, patient strengthening programs, community-focused care strategies, and the incorporation of nutritional therapy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Key Market Drivers Powering Chronic Kidney Disease Market Expansion and Growth?
The growth of the chronic kidney disease market is anticipated to be fueled by the rising incidences of kidney disease. These diseases, encompassing diverse conditions, impair the workings and structure of the kidneys. To prevent the further progression of kidney impairment, manage symptoms, and dodge complications, medication is utilized to regulate blood pressure in patients and minimize protein loss. For instance, data from July 2022 provided by the US-based Centers for Disease Control and Prevention reveals that about 15%, equivalent to 37 million people, in the US were suffering from kidney disease. As such, the escalating prevalence of kidney disease is a significant factor propelling the chronic kidney disease market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Chronic Kidney Disease Market?
The rising trend of product innovations is increasingly being observed in the chronic kidney disease market. To maintain their market standing, companies in the chronic kidney disease market are pioneering innovative products. For instance, Bayer, a biotech and pharmaceutical firm based in Germany, introduced the groundbreaking medicine Kerendia (finerenone) in August 2022. This medicine, which is the first-of-its-kind non-steroidal selective mineralocorticoid receptor antagonist, slows down the progression of chronic kidney disease in diabetes patients and deviates from existing treatments. It affects CKD progression and cardiovascular harm by impeding the overactivation of the mineralocorticoid receptor (MR).

What Are the Emerging Segments in the Chronic Kidney Disease Market?
The chronic kidney disease market covered in this report is segmented -

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) By Route of Administration: Oral, Intravenous, Subcutaneous
4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:
1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests
2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Who Are the Global Leaders in the Chronic Kidney Disease Market?
Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Which are the Top Profitable Regional Markets for the Chronic Kidney Disease Industry?
North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.